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Zika virus (ZIKV) infection during pregnancy was associated with microcephaly in neonates, but 
clinical and experimental evidence indicate that ZIKV also causes neurological complications in adults. 
However, the changes in neuron‑glial communication, which is essential for brain homeostasis, 
are still unknown. Here, we report that hippocampal slices from adult rats exposed acutely to ZIKV 
showed significant cellular alterations regarding to redox homeostasis, inflammatory process, 
neurotrophic functions and molecular signalling pathways associated with neurons and glial 
cells. Our findings support the hypothesis that ZIKV is highly neurotropic and its infection readily 
induces an inflammatory response, characterized by an increased expression and/or release of pro‑
inflammatory cytokines. We also observed changes in neural parameters, such as adenosine receptor 
A2a expression, as well as in the release of brain‑derived neurotrophic factor and neuron‑specific 
enolase, indicating plasticity synaptic impairment/neuronal damage. In addition, ZIKV induced a glial 
commitment, with alterations in specific and functional parameters such as aquaporin 4 expression, 
S100B secretion and glutathione synthesis. ZIKV also induced p21 senescence‑associated gene 
expression, indicating that ZIKV may induce early senescence. Taken together, our results indicate 
that ZIKV‑induced neuroinflammation, involving nuclear factor erythroid 2‑related factor 2 (Nrf2) 
and nuclear factor κB (NFκB) pathways, affects important aspects of neuron‑glia communication. 
Therefore, although ZIKV infection is transient, long‑term consequences might be associated with 
neurological and/or neurodegenerative diseases.
Zika virus (ZIKV) is a single-stranded RNA flavivirus, originally identified in Uganda in 1947, which has cur-
rently received attention because may cause severe damage in the fetal brain following maternal infection during 
gestation. In Brazil, the 2015 ZIKV outbreak was associated with microcephaly in neonates exposed to the virus 
during  pregnancy1. ZIKV markedly affects the cytoarchitecture of the brain, as well as induces neurochemical 
and molecular dysfunctions in neural  cells2–6. Current clinical and experimental data indicate that ZIKV also 
affects the mature brain, causing neurological complications including Guillain-Barré and other myelitis and 
encephalitis-like  illnesses7–11. However, the underlying neurochemical changes are still poorly understood. The 
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hippocampus is a crucial brain structure for learning and memory, and hippocampal damage leads to the progres-
sion of severe psychological and cognitive impairments. Hippocampal neurogenesis, which persists throughout 
life, is affected by immune activity triggered by pathogens including  ZIKV3,12.
Although neurons are the main focus of neuroscience research, glial cells are essential for the central nerv-
ous system (CNS), particularly because alterations in their functions can promote neuronal survival or  death13. 
Astrocytes are able to sense and respond to changes in their surrounding  microenvironment14,15. These cells also 
contribute to the formation and integrity of blood–brain barrier (BBB), affect axonal outgrowth and support 
neuronal metabolism and synaptic  activity16,17. Moreover, astrocytes actively participate in neuron-glial com-
munication, releasing trophic factors and inflammatory  mediators18,19. With regard to ZIKV infection, astrocytes 
are potentially the first cells targeted by ZIKV in the CNS, since they present the AXL receptor, a candidate 
receptor to host ZIKV in the  brain20,21. Indeed, microglial cells are the tissue-resident macrophage-like immune 
cells that continuously maintain an immune surveillance of the  CNS22, thus they can mediate inflammatory 
response after ZIKV exposure. The production of pro-inflammatory cytokines and other signalling molecules 
by microglia and/or astrocytes is part of the defence system against invading pathogens in the brain and are 
particularly orchestrated by nuclear factor κB (NFκB)  pathway23,24. Despite of both astrocytes and microglia 
presenting protective/defensive roles, these cells can shift their phenotype and release a wide range of harm-
ful signalling molecules. As glial cells regulate tissue recovery after injury, dysfunctions in these cells may be 
associated with neurological outcomes of ZIKV and represent a risk factor for neurodegenerative diseases and 
neuropsychiatric  disorders13,25,26.
In line with this, the aim of this study was to evaluate the changes in neuronal and glial functions in an 
ex vivo experimental model of acute hippocampal slices from adult rats submitted to ZIKV infection. Thus, we 
determined neurochemical parameters, inflammatory response, cellular and molecular pathways, including 
nuclear factor erythroid 2-related factor 2 (Nfr2) and NFκB, which are strongly associated with neuron-glia 
communication. This interaction is a crucial process for CNS homeostasis, and our findings provide the first 
evidence that ZIKV alters neuron-glia communication.
Results
ZIKV infected hippocampal slices from adult rats. We first investigated whether ZIKV17 could 
affect cellular viability and integrity of hippocampal slices. Thus, hippocampal slices were incubated for 1 or 
2 h with  102 to  106 plaque-forming units (PFU) as shown in the Fig. 1a, and it was observed loss in cellular 
integrity, measured by extracellular lactate dehydrogenase (LDH), at  106 PFU (Fig. 1b), without any change in 
MTT reduction assay (Fig. 1c). In addition, a significant increase in extracellular neuron-specific enolase (NSE) 
(Fig. 1d, Table 2) was observed, indicating neuron death at both exposure times. The viral doses of  105 and  106 
PFU induced tumour necrosis factor α (TNFα) and interleukin (IL) 1β release (Fig. 1e,f, Table 1), but extracellu-
lar NSE increased without change in LDH only at  105 PFU. Therefore, we performed the subsequent experiments 
using  105 PFU. Then, we evaluated the presence of ZIKV copies in acute hippocampal slices. Notably, we incu-
bated hippocampal slices with  105 PFU and after 1 or 2 h of the inoculum removal (as represented in the Fig. 1a), 
the ZIKV copies were maintained with a slight exponential increment (from  105 to  106) in the hippocampal slices 
(Fig. 2a), reinforcing its ability to infect neural cells. We used yellow fever virus (YFV17DD) as a comparative 
Flavivirus, and after incubating hippocampal slices with  105 PFU, the viral copies of YFV after the same times of 
incubations did not increase as much as the ZIKV (Fig. 2b).
Signalling mechanisms underlying ZIKV‑induced inflammatory response and redox imbal‑
ance. In order to characterize the inflammatory response, we measured mRNA expression levels of TNFα 
and IL1β, which increased after 1 and 2 h of ZIKV exposure (Table 1). However, their receptors, TNFR1 and 
IL1R1, respectively, did not change. In addition, the pro-inflammatory markers, IL6 and monocyte chemoat-
tractant protein 1 (MCP1), increased at 2 h of ZIKV exposure, while the anti-inflammatory cytokine IL10 sig-
nificantly decreased. ZIKV did not affect the mRNA expression of an alarmin that is specific to immune cells, 
high mobility group box 1 (HMGB1) (Table 1), but significantly decreased the secretion of the S100B, assumed 
to be an astrocyte-derived  alarmin27 (Table 2).
Other markers associated with inflammatory signalling were evaluated, including mRNA encoding NFκB 
p65, NFκB p50 and cyclooxygenase (COX) 2, which increased with ZIKV exposure (Table 1). As such, NFκB may 
be a key element in controlling ZIKV-induced damage in hippocampal slices, where it regulates the expression 
of cytokines, chemokines and  immunoreceptors28. To elucidate the response triggered by ZIKV, we measured 
levels of mRNA encoding for toll-like receptors (TLR) 2 and 4, which can bind virus, bacteria, pro-inflammatory 
cytokines and alarmins, such as  HMGB112. However, only TLR2 expression was increased by ZIKV (Table 1).
ZIKV exposure increased GSH levels and its rate-limiting enzyme, glutamate-cysteine ligase (GCL) (Table 1). 
This increase may be associated to astroglial reactivity, as GSH is the major brain antioxidant compound, whose 
production depends on astrocyte  activity29. Conversely, mRNA expression levels of the enzymes superoxide 
dismutase (SOD) 1 and 2 decreased, while inducible nitric oxide synthase (iNOS) increased. In addition, the 
expression of Nrf2 decreased in a time-dependent manner, as well as the mRNA levels of heme oxygenase 1 
(HO1), a fundamental defence mechanism for cells exposed to challenge stressors (Table 1).
Besides these pathways, Table 1 also displays that mRNA levels of phosphoinositide-3-kinase (PI3K) 
decreased, but its downstream signal, Akt, did not change, as well as phospho-PI3K immunocontent. In addi-
tion, p21 senescence-associated gene expression increased, indicating that ZIKV may induce early  senescence30. 
However, sirtuin 1 (SIRT1), a pathway that may counteract the inflammatory response and oxidative redox 
imbalance, did not change.
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ZIKV modulated neurotrophic factor release and adenosine receptor expression. Neuro-
trophic factors have been shown to modulate synaptic plasticity, neural response and recovery. ZIKV induced 
a fast increase in brain-derived neurotrophic factor (BDNF) and glial cell-derived neurotrophic factor (GDNF) 
release, as well as vascular endothelial growth factor (VEGF) mRNA levels (Table 2). However, 2 h afterwards, 
we observed only a decrease in BDNF secretion.
Neurotrophic factors/synaptic plasticity are closely associated with brain adenosine receptors, which are 
also involved in  neuroinflammation31. In our experimental model, we observed that ZIKV increased only the 
expression of adenosine receptor A2a (Table 2).
ZIKV changed specific neuron/glial parameters. To characterize the different commitment between 
neurons and glial cells, we examined some specific parameters. With regard to glial markers, ZIKV quickly 
Figure 1.  Effects of ZIKV on the hippocampus of adult rats. (a) Experimental design of ZIKV infection. 
Hippocampal slices (0.3 mm thickness) were obtained from adult rats and were maintained for an equilibration 
period of up to 1 h (cellular recovery), following ZIKV adsorption  (102–106 PFU) or non-infection control 
for 1 h. The inoculum was then washed out, and the slices were maintained for an additional 1 or 2 h; 
(b) extracellular LDH activity; (c) MTT reduction; (d) extracellular NSE activity. The line indicates the 
non-infection control value, assumed as 100%. Data represent means ± SEM of at least four experimental 
determinations performed in quadruplicate, analyzed by one-way ANOVA followed by Tukey’s test. Values 
of P < 0.05 were considered significant (a indicates difference from control condition; b indicates difference 
between 1 and 2 h incubations after ZIKV inoculation). The release of TNFα (e) and IL1β (f) was evaluated 
using the extracellular medium of hippocampal slices after incubation with ZIKV  (102–106 PFU) or non-
infection control (first column in the graphs). Data represent means ± SEM of at least four experimental 
determinations performed in quadruplicate, analyzed by one-way ANOVA followed by Tukey’s test. Values 
of P < 0.05 were considered significant (a indicates difference from control condition; b indicates difference 
between 1 and 2 h incubations after ZIKV inoculation).
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increased the mRNA expression of aquaporin 4 (AQP4) (Table 2), whose role in neuroinflammation and neu-
rodegenerative diseases has been increasingly  highlighted32. As commented above, S100B secretion decreased 
after ZIKV exposure; however, the expression of glial fibrillary acidic protein (GFAP) and other specific markers 
such as glutamate transporters (GLAST and GLT1) and glutamine synthetase (GS) did not change in the acute 
presence of ZIKV (Table 2). In contrast, ZIKV exposure at 2 h increased the mRNA expression of vimentin and 
nestin, two other filament intermediary proteins found in astrocytes.
Regarding neurons, although there was an increase in extracellular NSE levels, there was no alteration in the 
expression of other specific markers, such as the EAAC1 glutamate transporter, N-methyl-D-aspartate receptor 
1 (NMDA-R1), synaptophysin and β-tubulin III, after ZIKV exposure (Table 2).
Discussion
Although ZIKV was initially associated with microcephaly in neonates and developmental anomalies, increasing 
evidence has shown that it can replicate in adult brain tissue, being able to affect synapses and induce cognitive 
 deficits3,7–10. Herein, for the first time, we reported that ZIKV is able to quickly infect hippocampal slices from 
adult rats, acutely causing a wide range of cellular and molecular alterations, regarding to redox, inflammatory 
Table 1.  Effects of ZIKV on inflammatory/redox signaling and associated pathways. Hippocampal slices from 
adult Wistar rats were incubated with medium containing ZIKV  (102 to  106 PFU) for an adsorption period 
of 1 h. Afterwards, this medium was exchanged for fresh saline medium for 1 h or 2 h, and the parameters 
presented in Table were measured, as described in the “Methods”: section. Data are expressed as: (i) pg/
mL for ELISA assays; (ii) fold increase for mRNA levels (RT-PCR); (iii) percentages of control for protein 
levels (Western blotting—WB); (iv) GSH content (fluorimetric assay—FA). Differences among groups were 
statistically analyzed using one-way analysis of variance (ANOVA), followed by Tukey’s test (n = 6 per group, 
except for the WB analysis in which at least three experimental determinations were performed). Values 
of P < 0.05 were considered significant. P values are indicated in the Table. Treatment groups that differ 










2 h (D) Method F P Post hoc
Inflammatory signaling
TNFα (pg/mL) 108 ± 8 205 ± 18 111 ± 4 214 ± 9 ELISA 27.2  < 0.0001 B ≠ A; D ≠ C
TNFα (mRNA) 1.0 ± 0.09 2.1 ± 0.12 0.9 ± 0.08 2.7 ± 0.15 RT-PCR 60.7  < 0.0001 B ≠ A; D ≠ C; D ≠ B
TNFR1 (mRNA) 1.0 ± 0.06 1.0 ± 0.04 1.0 ± 0.04 1.1 ± 0.10 RT-PCR 0.374  > 0.05
IL1β (pg/mL) 77 ± 4 135 ± 4 78 ± 2 155 ± 11 ELISA 50.66  < 0.0001 B ≠ A; D ≠ C
IL1β (mRNA) 1.0 ± 0.04 2.1 ± 0.10 1.0 ± 0.07 3.2 ± 0.22 RT-PCR 64.71  < 0.0001 B ≠ A; D ≠ C; D ≠ B
IL1R1 (mRNA) 1.0 ± 0.09 1.0 ± 0.12 1.1 ± 0.12 1.2 ± 0.13 RT-PCR 0.617  > 0.05
IL6 (pg/mL) 70 ± 3 74 ± 3 69 ± 2 98 ± 2 ELISA 27.19  < 0.0001 D ≠ C; D ≠ B
IL10 (pg/mL) 23 ± 1 23 ± 1 22 ± 1 7 ± 1 ELISA 43.13  < 0.0001 D ≠ C; D ≠ B
MCP1 (pg/mL) 27 ± 1 25 ± 2 26 ± 1 44 ± 4 ELISA 16.58  < 0.0001 D ≠ C; D ≠ B
HMGB1 (mRNA) 1.0 ± 0.03 0.9 ± 0.08 0.9 ± 0.06 1.1 ± 0.09 RT-PCR 1.252  > 0.05
COX2 (mRNA) 1.0 ± 0.04 1.7 ± 0.06 0.9 ± 0.06 2.5 ± 0.13 RT-PCR 81.97  < 0.0001 B ≠ A; D ≠ C; D ≠ B
TLR2 (mRNA) 1.0 ± 0.06 1.2 ± 0.14 1.0 ± 0.08 2.2 ± 0.17 RT-PCR 20.46  < 0.0001 D ≠ C; D ≠ B
TLR4 (mRNA) 1.0 ± 0.07 1.0 ± 0.10 1.0 ± 0.06 1.2 ± 0.10 RT-PCR 1.146  > 0.05
NFκB p65 (mRNA) 1.0 ± 0.05 1.7 ± 0.13 0.9 ± 0.05 2.3 ± 0.21 RT-PCR 25.77  < 0.0001 B ≠ A; D ≠ C; D ≠ B
NFκB p50 (mRNA) 1.0 ± 0.07 0.9 ± 0.07 1.1 ± 0.04 1.4 ± 0.10 RT-PCR 8.974 0.0006 D ≠ C; D ≠ B
Redox signaling
Nrf2 (mRNA) 1.0 ± 0.02 0.7 ± 0.04 1.1 ± 0.03 0.5 ± 0.04 RT-PCR 69.18  < 0.0001 B ≠ A; D ≠ C; D ≠ B
HO1 (mRNA) 1.0 ± 0.03 0.7 ± 0.03 1.0 ± 0.03 0.4 ± 0.02 RT-PCR 119.1  < 0.0001 B ≠ A; D ≠ C; D ≠ B
iNOS (mRNA) 1.0 ± 0.07 1.0 ± 0.10 0.9 ± 0.06 1.7 ± 0.10 RT-PCR 19.16  < 0.0001 D ≠ C; D ≠ B
SOD1 (mRNA) 1.0 ± 0.07 0.6 ± 0.06 1.0 ± 0.02 0.5 ± 0.08 RT-PCR 20.95  < 0.0001 B ≠ A; D ≠ C
SOD2 (mRNA) 1.0 ± 0.02 0.6 ± 0.02 1.1 ± 0.03 0.4 ± 0.03 RT-PCR 129.3  < 0.0001 B ≠ A; D ≠ C; D ≠ B
GSH (%) 100 ± 12 100 ± 23 100 ± 3 158 ± 20 FA 3.463 0.026 D ≠ C
GCL (mRNA) 1.0 ± 0.06 1.1 ± 0.07 1.1 ± 0.05 2.0 ± 0.09 RT-PCR 42.11  < 0.0001 D ≠ C; D ≠ B
Other pathways
PI3K (mRNA) 1.0 ± 0.04 0.9 ± 0.06 0.9 ± 0.04 0.5 ± 0.05 RT-PCR 25.71  < 0.0001 D ≠ C; D ≠ B
PI3K (protein) 100 ± 33 76 ± 29 45 ± 10 61 ± 23 WB 0.789  > 0.05
Akt (mRNA) 1.0 ± 0.08 1.0 ± 0.05 1.1 ± 0.05 1.0 ± 0.08 RT-PCR 0.325  > 0.05
Akt (protein) 100 ± 19 92 ± 19 108 ± 20 103 ± 13 WB 0.140  > 0.05
p21 (mRNA) 1.0 ± 0.04 0.9 ± 0.05 1.0 ± 0.03 1.5 ± 0.04 RT-PCR 39.51  < 0.0001 D ≠ C; D ≠ B
SIRT1 (mRNA) 1.0 ± 0.08 0.8 ± 0.09 0.9 ± 0.08 0.9 ± 0.10 RT-PCR 0.765  > 0.05
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Figure 2.  Viral copies detection in hippocampal slices. Hippocampal slices were infected with  105 PFU of 
ZIKV or YFV (used as a comparative Flavivirus) according the experimental design depicted in Fig. 1a. Non-
infection controls were simultaneously carried out. Quantitative PCR for ZIKV (a) and YFV (b) was performed 
to determinate viral copies in the hippocampal slice after 1 h or 2 h incubation. Bars represent means ± SEM of 
three experimental determinations (ND not detectable).
Table 2.  Effects of ZIKV on neurotrophic factors, adenosine receptors, and specific neuron and glial 
parameters. Hippocampal slices from adult Wistar rats were incubated with medium containing ZIKV  (102 to 
 106 PFU) for an adsorption period of 1 h. Subsequently, this medium was exchanged for fresh saline medium 
for 1 h or 2 h, and the parameters presented in Table were measured, as described in the “Methods” section. 
Data are expressed as: (i) pg/mL for ELISA assays, except for S100B ELISA, expressed as the percentage of 
control; (ii) fold increase for mRNA levels (RT-PCR); (iii) percentages of control for protein levels (Western 
blotting—WB). Differences among groups were statistically analyzed using one-way analysis of variance 
(ANOVA), followed by Tukey’s test (n = 6 per group, except for the WB analysis in which at least three 
experimental determinations were performed). Values of P < 0.05 were considered significant. P values 
are indicated in the Table. Treatment groups that differ significantly are listed in the Post hoc column. The 









2 h (D) Method F P Post hoc
Neurotrophic signaling
BDNF (pg/mL) 64 ± 2 87 ± 4 62 ± 2 39 ± 4 ELISA 42.82  < 0.0001 B ≠ A; D ≠ C; D ≠ B
GDNF (pg/mL) 71 ± 4 95 ± 5 68 ± 5 115 ± 2 ELISA 28.57  < 0.0001 B ≠ A; D ≠ C; D ≠ B
VEGF (mRNA) 1.0 ± 0.06 1.7 ± 0.12 1.0 ± 0.07 2.2 ± 0.10 RT-PCR 40.19  < 0.0001 B ≠ A; D ≠ C; D ≠ B
Adenosine receptors
A1 (mRNA) 1.0 ± 0.06 1.1 ± 0.06 0.9 ± 0.05 0.9 ± 0.04 RT-PCR 3.077  > 0.05
A2a (mRNA) 1.0 ± 0.02 1.1 ± 0.10 0.9 ± 0.05 1.6 ± 0.05 RT-PCR 28.03  < 0.0001 D ≠ C; D ≠ B
A2b (mRNA) 1.0 ± 0.04 1.0 ± 0.03 1.0 ± 0.03 1.0 ± 0.02 RT-PCR 0.120  > 0.05
A3 (mRNA) 1.0 ± 0.05 1.1 ± 0.05 1.1 ± 0.04 1.1 ± 0.06 RT-PCR 1.122  > 0.05
Specific glial parameters
GFAP (mRNA) 1.0 ± 0.05 0.8 ± 0.05 0.9 ± 0.07 0.9 ± 0.07 RT-PCR 0.656  > 0.05
GFAP (protein) 100 ± 7 103 ± 8 87 ± 21 75 ± 29 WB 0.551  > 0.05
Vimentin (mRNA) 1.0 ± 0.18 0.7 ± 0.03 0.8 ± 0.09 1.5 ± 0.19 RT-PCR 7.798 0.0006 D ≠ C; D ≠ B
Nestin (mRNA) 1.0 ± 0.11 0.8 ± 0.05 0.7 ± 0.03 1.4 ± 0.10 RT-PCR 9.250 0.0005 D ≠ C; D ≠ B
AQP4 (mRNA) 1.0 ± 0.06 1.1 ± 0.05 1.0 ± 0.10 1.7 ± 0.07 RT-PCR 19.58  < 0.0001 D ≠ C; D ≠ B
GLT1 (mRNA) 1.0 ± 0.08 1.1 ± 0.10 0.8 ± 0.07 0.9 ± 0.08 RT-PCR 1.98  > 0.05
GLAST (mRNA) 1.0 ± 0.05 1.1 ± 0.08 0.8 ± 0.08 0.9 ± 0.10 RT-PCR 2.437  > 0.05
GS (mRNA) 1.0 ± 0.10 1.1 ± 0.04 0.9 ± 0.06 1.0 ± 0.12 RT-PCR 0.388  > 0.05
S100B (%) 100 ± 6 112 ± 13 100 ± 13 38 ± 4 ELISA 10.48  < 0.0001 D ≠ C; D ≠ B
Specific neuron markers
NSE (%) 100 ± 2 136 ± 4 100 ± 2 165 ± 8 LA 67.25  < 0.0001 B ≠ A; D ≠ C
EAAC1 (mRNA) 1.0 ± 0.07 0.9 ± 0.04 1.0 ± 0.06 1.1 ± 0.10 RT-PCR 1.842  > 0.05
NMDA-R1 (protein) 100 ± 23 100 ± 21 52 ± 22 57 ± 27 WB 1.258  > 0.05
Synaptophysin (protein) 100 ± 11 79 ± 12 101 ± 7 112 ± 22 WB 1.027  > 0.05
β-tubulin III (protein) 100 ± 11 129 ± 23 106 ± 20 93 ± 18 WB 0.754  > 0.05
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and neurotrophic parameters (Fig. 3). These alterations can affect neuron-glia communication, which is crucial 
to brain homeostasis. Thus, although ZIKV infection can be transient, it can induce significant changes in the 
adult brain functionality, whose long-term consequences are unknown, but might become an important health 
 concern25,26.
Hippocampus is a crucial region involved in learning and long-term memory processes. This brain structure 
is susceptible to endogenous and/or exogenous factors that can lead synaptic plasticity impairment, which is 
often manifested in neurodegenerative  diseases33,34. Interestingly, hippocampus seems to be an important target 
region for ZIKV. Previously, it has been demonstrated that adult neural stem cells from hippocampus are vul-
nerable to ZIKV, which causes cell death and reduced  proliferation35. Although it has been suggested that glial 
cells, particularly astrocytes, are mostly affected by ZIKV because it can bind to AXL  receptor20,21, recent results 
in cultured mouse hippocampal slices indicate acute ZIKV infection in neurons and not in astrocytes, contrary 
to expectations based on entry via AXL  receptors3.
Acute ZIKV exposure in adult hippocampal slices caused a markedly inflammatory response, which can 
alter neuronal synaptic communication. Notably, neuroinflammation is a common point between congenital 
microcephaly in newborns and neurological complications in childhood and  adults36. Although glial cells are the 
main cells responsible for producing and releasing inflammatory mediators, we do not know the origin of these 
cytokines at this time, and neurons could be also considered as a source. Accordingly, ZIKV-infected neurons 
in culture exhibit increased levels of TNFα and IL1β37. Moreover, as previously reported in viral encephalitis, 
neurons can be primary targets releasing mediators by informing neighbouring cells and attracting immune 
cells from the  blood38. During ZIKV infection, the permeability of the BBB can increase as a consequence of the 
overproduction of cytokines, thus favouring the access of peripheral cells and ZIKV to the  brain36. In line with 
this, peripheral blood mononuclear cells were identified as important cellular targets of American ZIKV strain 
infection, and for promoting ZIKV  spread39. It is important to note that astrocytes are functional elements in 
the BBB, thus these cells can contribute to propagation and progress of ZIKV infection, causing injury of neural 
cells through direct infection-induced and/or indirect immune-mediated  mechanisms40–42.
Astrocytes play an important role in the CNS antioxidant defence, since they can provide glutathione (GSH) 
and superoxide dismutase (SOD) to  neurons43,44. Changes in this function can impair the adult brain, contrib-
uting to further neurological manifestations related to ZIKV infection. Interestingly, we observed an increase 
in both glutamate-cysteine ligase (GCL) expression and in the GSH content, probably as an early compensa-
tory mechanism in response to ZIKV exposure. In contrast, ZIKV acutely modulated the expression of other 
genes related to redox homeostasis/oxidative stress; particularly, there was a downregulation of HO1, SOD1 and 
SOD2, and an upregulation of iNOS. Accordingly, a recent study in human iPSC-derived astrocytes showed that 
ZIKV infection induced oxidative stress, mitochondrial failure and DNA  damage2. ZIKV-induced dysfunctions 
in mitochondrial activity are also potentially associated with excitotoxicity. Notably, ZIKV-infected neurons 
release increased levels of  glutamate37. Although we did not observe changes in the expressions of astrocytic and 
Figure 3.  Heatmaps representing gene expression after acute ZIKV exposure in hippocampal slices. (a) The 
relative mRNA expression in the different experimental groups. Each square represents the mean of the group 
and the color scale is shown at the right. The gene expressions of hippocampal slices after 1 h (b) or 2 h (c) ZIKV 
exposure were analyzed as Z-score values. Each square represents a biological replicate (n = 6 per group).
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neuronal glutamate transporters, their activity may be impaired by  oxidation45, potentially causing excitotoxic-
ity. In addition, this process is potentiated by  Ca2+ release from the mitochondria and endoplasmic reticulum, 
and ZIKV can interfere with  Ca2+ uptake by  mitochondria2. However, at least acutely, ZIKV did not modulate 
NMDA-R1 protein levels.
The differential expression profile observed for TLRs may indicate differences in infection and immunity in 
response to ZIKV. Although TLRs trigger inflammatory and antiviral responses, they can also modulate adult 
hippocampal  neurogenesis12. In the context of acute hippocampal injury, neurotrophic factors have been shown 
to modulate neural response and  recovery46. The decrease of BDNF could contribute to impair synaptic plasticity. 
However, synaptophysin, a pre-synaptic protein widely used as a marker of synaptic plasticity, was not affected 
at this short time. In addition, considering that A2a receptor is associated with synaptic plasticity and inflam-
matory  process47,48, the increased expression of this receptor induced by ZIKV, can be a possible link between 
ZIKV, neuroinflammation and long-term neurological  diseases26. It is important to note that the decrease in 
BDNF and increase in A2a perhaps favour the release of glutamate in  neurons49, a common event associated with 
excitotoxicity and age-related diseases. In this sense, ZIKV-induced an upregulation of the senescence marker 
p21 in hippocampal slices. Moreover, the protein S100B is frequently used as a marker of astrocyte activation, and 
can produce either neurotrophic or deleterious effects, depending on the  concentration50, showed a decreased 
release, suggesting that ZIKV also affects trophic signalling mediated by astrocytes.
Since there is a close relationship between inflammation and redox signalling, we investigated classical 
pathways that interconnect these events in neural cells, namely NFκB and Nfr2. Nfr2 is a transcription factor 
involved in the adaptive response to cellular stress, including the oxidative stress induced during the inflamma-
tory response, and their target genes, which induce antioxidant enzyme production, GSH synthesis and eventually 
inhibit cytokine-mediated  inflammation51. Increasing evidence has suggested that activation of Nrf2 is more 
restricted to  astrocytes52. While the increased expression and activity of Nrf2 are associated with protective 
mechanisms, deficiencies have been correlated with exacerbated astrogliosis, GFAP expression and worsen-
ing of inflammatory parameters in a mouse model of neurodegeneration, as well as with impaired neuronal 
differentiation of neural stem cells in the subgranular zone of the  hippocampus53. Furthermore, in the CNS, 
cell-type specific pathological roles of NFκB have been described, including aberrant synapse to nuclear com-
munication in neurons, and glial activation leading to chronic neuroinflammation, with consequent neuronal 
cell  death28. Considering that there is an interplay between inflammatory and oxidative signals, in which Nrf2 
depletion enhances NFκB signaling, and the latter eventually modulates Nrf2  transcription51, data indicate that 
the transcription factors, NFκB and Nrf2, may be important mechanistic partners in the altered neuron-glial 
communication observed after ZIKV exposure.
Our data support the hypothesis that ZIKV is highly neurotropic and its infection readily increases the 
expression of intermediate filaments, vimentin and nestin, found in astrocytes and precursor neural cells, which 
could contribute to the aberrant brain cytoarchitecture found in fetuses exposed to ZIKV. Consistent with this 
increased expression of vimentin and nestin, evidence has suggested that an immature phenotype may re-emerge 
in astrocytes in the pathological adult brain, in an effort to promote synapse  remodelling54. Moreover, and just 
as importantly, our study has generated data to indicate that ZIKV-induced neural damage occurs in the mature 
brain, particularly in the hippocampus. Based on GFAP expression and content, astrocytes may appear to be 
unaffected by acute ZIKV exposure. However, other specific and functional parameters such as AQP4, S100B 
secretion, GSH biosynthesis, and underlying glial signalling pathways indicate acute glial commitment (Fig. 4). 
In summary, our findings from ex vivo hippocampal slices acutely exposed to ZIKV, indicate that ZIKV-induced 
neuroinflammation affects important aspects of neuron-glia communication that are commonly affected in 
neurodegenerative diseases.
Figure 4.  Schematic illustration of some cellular targets of ZIKV in neural cells. Our data reinforce the strong 
neurotropism of ZIKV, which was able to readily increase the expression and/or release of pro-inflammatory 
mediators, such as cytokines and iNOS. Inflammatory response is mainly coordinated by NFκB. In contrast, 
Nrf2 and its transcriptional products, such as HO1, are important regulators of adaptive responses to cellular 
stresses. HO1 is able to counteract inflammatory response and NFκB transcription activity. However, both Nrf2 
and HO1 were downregulated by ZIKV exposure. More specific neuronal and astroglial ZIKV-induced effects 
could also be observed. A decrease in BDNF release, an increase in NSE and in A2a receptor gene expression 
can be mainly attributed to neurons (although A2a can be also expressed by astrocytes and microglia). 
Moreover, a decrease in S100B release, as well as an increase in mRNA levels of AQP4 and in GSH content can 
indicate an acute ZIKV-induced glial commitment in the hippocampus of adult rats.
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Methods
ZIKV. Brazilian ZIKV strain 17 (ZIKV17, 6 passages in VERO cells; kindly provided by Dr. E. Durigon, Insti-
tute of Biomedical Sciences, University of São  Paulo55—GenBank sequence accession number MH882541.1) and 
YFV vaccinal strain 17DD (produced by Instituto de Tecnologia em Imunobiológicos Bio-Manguinhos), were 
propagated in African green monkey kidney E6 (VERO E6) cells (ATCC CRL-1586). Viruses were also titrated 
on VERO E6, using a standard plaque assay. Viral stocks were maintained at − 80 °C.
Animals. Male Wistar rats (30 days old) were obtained from the breeding colony of the Department of Bio-
chemistry (Federal University of Rio Grande do Sul, Porto Alegre, Brazil) and maintained under a controlled 
environment (12-h light/12-h dark cycle; 22 ± 1 °C; ad libitum access to food and water). All animal experiments 
were performed in accordance with the National Institutes of Health (NIH) Guide for the Care and Use of Labo-
ratory Animals and were approved by the Animal Care and Use Committees of Federal University of Rio Grande 
do Sul (process numbers 24419 and 36949) and Instituto de Cardiologia/Fundação Universitária de Cardiologia 
(CEUA-IC/FUC 001/2018).
Hippocampal slices preparation. The hippocampi were dissected from brain and transversally sliced 
(0.3 mm thickness) using a Mcllwain Tissue  Chopper56. Slices were then transferred immediately into 24-well 
culture plates (one slice per well), with each well containing 0.3 mL of physiological saline medium (composi-
tion in mM: 120 NaCl; 2 KCl; 1  CaCl2; 1  MgSO4; 25 HEPES; 1  KH2PO4 and 10 glucose, adjusted to pH 7.4 and 
previously oxygenated for 15 min with  O2). The medium used for slices was exchanged every 15 min with fresh 
saline at room temperature (equilibration period) for up to 60 min. It is important to note that this is an acute 
model of hippocampal slices, which are viable up to 5 h after  preparation57.
ZIKV infection of hippocampal slices. Following the equilibration period, the medium of hippocampal 
slices was removed and replaced with 0.3  mL fresh saline containing different PFU of ZIKV  (102–106 or an 
equivalent volume of non-infection control medium) or YFV  (102–106 or an equivalent volume of non-infection 
control medium) for an adsorption period of 1 h at 37 °C. Subsequently, the inoculum was exchanged with fresh 
saline medium and hippocampal slices were maintained at 37 °C for 1 h or 2 h. The extracellular medium and 
slices were harvested at these two time points for subsequent analyses.
Membrane integrity and metabolic activity assays. MTT reduction assay slices were treated with 
0.5 mg/mL of MTT for 30 min at 30 °C. The MTT formazan was dissolved in  DMSO56. Absorbance values were 
measured at 560 and 650 nm. Results are expressed as percentages of the non-infection control value.
Lactate dehydrogenase assay the release of the enzyme lactate dehydrogenase was assessed measuring its activ-
ity in the extracellular medium (100 μL) of slices using a commercial UV assay from Bioclin (Brazil). Results are 
expressed as percentages of the non-infection control value.
Neuron-specific enolase (NSE) activity extracellular NSE was measured using an eletrochemiluminescent 
assay purchased from Roche Diagnostics. The assay is a double sandwich that uses an antibody anti-NSE bound 
with ruthenium, which produces light emission when excited. The reaction and quantification were performed 
by the equipment Elecsys-2010 (Roche Diagnostics Corporation). Results are expressed as percentages of the 
non-infection control value.
Cytokine measurement. Cytokine levels were measured in the extracellular medium using ELISA kits for 
TNFα (Peprotech), IL1β, IL6, IL10 and MCP1 (Invitrogen)31. The results are expressed in pg/mL and the average 
minimum sensitivity of the ELISA kits detection was: 25.0 pg/mL for TNFα; 12 pg/mL for IL1β; 16 pg/mL for 
IL6; 3 pg/mL for IL10; and 5 pg/mL for MCP1.
Trophic factor release. BDNF and GDNF levels were measured in the extracellular medium, using com-
mercial ELISA kits from Invitrogen and R&D Systems,  respectively31. The results are expressed in pg/mL. The 
ELISA kits detect a minimum of 12 pg/mL for BDNF and 31.2 pg/mL for GDNF.
S100B secretion measurement. S100B secretion was measured by an enzyme-linked immunosorbent 
assay, as previously  described58. Briefly, 50 µL of extracellular medium from slices and 50 µL of Tris buffer were 
incubated for 2 h on a microtiter plate previously coated with monoclonal anti-S100B (SH-B1; Sigma-Aldrich). 
Next, the samples were incubated with polyclonal anti-S100B (Dako) for 30 min, and then, peroxidase-conju-
gated anti-rabbit antibody (Amersham) was added for a further 30 min incubation period. A colorimetric reac-
tion with o-phenylenediamine (Sigma-Aldrich) was observed at 492 nm. Results are expressed as percentages of 
the non-infection control value.
GSH levels. GSH levels were fluorometrically assessed as previously  described58. Hippocampal slices were 
suspended in a 100 mM sodium phosphate buffer with 140 mM KCl (pH 8.0) containing 5 mM EDTA. After that, 
protein was precipitated with 1.7% metaphosphoric acid. The supernatant was assayed with o-phthaldialdehyde 
(at a concentration of 1 mg/mL methanol; Sigma-Aldrich) at room temperature for 15 min. Fluorescence was 
measured using excitation and emission wavelengths of 350 and 420 nm, respectively. A calibration curve was 
performed with standard GSH (Sigma-Aldrich) solutions at concentrations ranging from 0 to 500 μM. Results 
are expressed as percentages of the non-infection control value.
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RNA extraction and quantitative RT‑PCR. Total RNA was isolated from hippocampal slices (control 
and infected) using TRIzol Reagent (Invitrogen, Carlsbad, CA). Extracted RNA (1 μg) was submitted to cDNA 
synthesis by High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Thermo Fisher Scientific). 
Quantitative PCR for viral copies determination was performed in total volumes of 12.5 µL containing 3 µL of 
cDNA, 6.25 µL of 2× Platinum quantitative PCR SuperMix-UDG (Invitrogen—Life Technologies), 200 nM each 
of forward and reverse primers (ZIKV 1086 and ZIKV  1162c59; RP-YFV and FP-YFV60). Amplification was car-
ried out in a StepOne Real-Time PCR system (Applied Biosystems, Thermo Fisher Scientific) under the follow-
ing conditions; uracil DNA glycosylase (UDG) incubation at 50 °C for 2 min; initial denaturation and Platinum 
Taq activation at 95 °C for 2 min, followed by 40 cycles of amplification (15 s at 95 °C and 30 s at 60 °C). All 
real-time assays were performed in triplicate and results depict the means of these triplicate values. Viral RNA 
quantification was estimated in relation to ZIKV or YFV standard curves  (108 to 10 copies) and data analysis was 
performed with the StepOne software v2.2.2.
For neural gene expression, the messenger RNAs (mRNAs) encoding TNFα (#Rn99999017_m1), TNF recep-
tor 1 (TNFR1; #Rn01492348_m1), IL1β (#Rn00580432_m1), IL1 receptor type I (IL1R1; #Rn00565482_m1), 
HMGB1 (#Rn02377062_g1), COX2 (#Rn01483828_m1), TLR2 (#Rn02133647_s1), TLR4 (#Rn00569848_m1), 
NFκB p65 (#Rn01502266_m1), NFκB p50 (#Rn01399572_m1), Nrf2 (#Rn00582415_m1), HO1 (#Rn01536933_
m1), iNOS (#Rn00561646_m1), SOD1 (#Rn00566938_m1), SOD2 (#Rn00690588_g1), GCL (#Rn00689046_
m1), PI3K (#Rn01769524_m1), Akt (#Rn00442194_m1), p21 (#Rn 00589996_m1), SIRT1 (#Rn01428096_
m1), VEGF (#Rn01511602_m1), adenosine receptors A1 (#Rn00567668_m1), A2a (#Rn00583935_m1), A2b 
(#Rn00567697_m1), A3 (#Rn00563680_m1), GFAP (#Rn00566603_m1), vimentin (#Rn00667825_m1), nestin 
(#Rn00564394_m1), AQP4 (#Rn00563196_m1), GLT1 (#Rn00691548_m1), GLAST (#Rn00570130_m1), GS 
(#Rn01483107_m1), EAAC1 (#Rn00564705_m1), and β-actin (#Rn00667869_m1) were quantified using the 
TaqMan real-time RT-PCR system using inventory primers and probes purchased from Applied Biosystems 
(Thermo Fisher Scientific), as referred for each  gene31. Target mRNA levels were normalized to β-actin levels. 
Results were analyzed employing the  2−ΔΔCt method and expressed relative to the levels of non-infection control 
conditions (1 h).
Western blotting analysis. Hippocampal slices were lysed in a solution containing 4% SDS, 2 mM EDTA, 
1  mM  Na3VO4, 10  mM NaF and 50  mM Tris–HCl (pH 6.8). Samples were separated by SDS/PAGE (20  μg 
protein per sample) and transferred to nitrocellulose membranes using a semi dry blotting apparatus (1.2 mA/
cm2; 1 h). The membranes were blocked with 2% albumin in Tris-buffered saline with Tween 20 (T-TBS) and 
then incubated overnight (4 °C) with anti-PI3K (1:2000, Cell Signaling), anti-Akt (1:2000; Cell Signaling), anti-
NMDAR1 (1:5000; Millipore), anti-GFAP (1:5000; Sigma-Aldrich), anti-synaptophysin (1:5000; Millipore), 
anti-tubulin βIII (1:5000; Abcam), or anti-actin (1:5000; Millipore). β-actin was used as a loading control. Sub-
sequently, the membranes were incubated for 1 h at room temperature with horseradish peroxidase-conjugated 
anti-mouse IgG or anti-rabbit IgG (1:10,000; GE Healthcare) for 1 h. The chemiluminescence signal was detected 
in an Image Quant LAS4010 system (GE Healthcare) using an ECL kit (GE Healthcare). Results are expressed as 
percentages relative to non-infection control conditions.
Statistical analyses. Differences among groups were statistically analyzed using one-way analysis of vari-
ance (ANOVA), followed by Tukey’s test. All analyses were performed using the GraphPad Prism 7 (GraphPad 
Software, Inc., La Jolla, CA, USA). Values of P < 0.05 were considered significant. Heatmaps were created using 
GraphPad Prism 7 and  Heatmapper61.
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding 
author on reasonable request.
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